Lima, Teofila S.

HRN: 11-48-62  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/16/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/16/2025
05/23/2025
IV
1.5g
Q6
CAP MR
Waiting Final Action 
05/16/2025
CLARITHROMYCIN 500MG (CAP)
05/16/2025
05/23/2025
PO
500mg
BID
CAP MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: